Authors: VANHOECKE C FU D DEGRAVE D VOET P LEBACQ E

Citation: C. Vanhoecke et al., CLINICAL AND IMMUNOLOGICAL ASSESSMENT OF A CANDIDATE LYME-DISEASE VACCINE IN HEALTHY-ADULTS - ANTIBODY PERSISTENCE AND EFFECT OF A BOOSTER DOSE AT MONTH 12, Vaccine, 16(17), 1998, pp. 1688-1692

Authors: VANHOECKE C COMBERBACH M DEGRAVE D DESMONS P FU D HAUSER P LEBACQ E LOBET Y VOET P

Citation: C. Vanhoecke et al., EVALUATION OF THE SAFETY, REACTOGENICITY AND IMMUNOGENICITY OF 3 RECOMBINANT OUTER SURFACE PROTEIN (OSPA) LYME VACCINES IN HEALTHY-ADULTS, Vaccine, 14(17-18), 1996, pp. 1620-1626

Authors: DEROUBAIX X STOCKIS A ALLEMON AM LEBACQ E ACERBI D VENTURA P

Citation: X. Deroubaix et al., ORAL BIOAVAILABILITY OF CHF1194, AN INCLUSION COMPLEX OF PIROXICAM AND BETA-CYCLODEXTRIN, IN HEALTHY-SUBJECTS UNDER SINGLE-DOSE AND STEADY-STATE CONDITIONS, European Journal of Clinical Pharmacology, 47(6), 1995, pp. 531-536

Authors: STOCKIS A BORZIO F DEROUBAIX X GASPARI F JEANBAPTISTE B LEBACQ E LINS R PAVESIO D PELOZI GC ROSILLON D

Citation: A. Stockis et al., PHARMACOKINETICS OF BRODIMORPIM IN SPECIA L POPULATIONS, Journal of chemotherapy, 6, 1994, pp. 109-117

Authors: LEBACQ E GLINE JP JOUE P STOCKIS A CALDERON P VANSCHOOR O DEROUBAIX X SCHWEGLER F

Citation: E. Lebacq et al., EXPLORATORY-STUDY OF THE DECONGESTIVE EFFECT OF RHINOPRONT SYRUP IN ADULTS AND IN CHILDREN WITH ACUTE RHINITIS, Clinical trials and meta-analysis, 29(2-3), 1994, pp. 113-124

Authors: STOCKIS A BORZIO F DEROUBAIX X GASPARI F JEANBAPTISTE B LEBACQ E LINS R PAVESIO D PELOZI GC ROSILLON D

Citation: A. Stockis et al., PHARMACOKINETICS OF BRODIMOPRIM IN SPECIAL POPULATIONS, Journal of chemotherapy, 5(6), 1993, pp. 480-487